News
07-11-2012, 02:14 AM
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel - undetected by normal cells - through the bloodstream until activated by specific cancer proteins...
More... (http://www.medicalnewstoday.com/releases/247648.php)
More... (http://www.medicalnewstoday.com/releases/247648.php)